Women’s health company and medtech giant Hologic’s (NSDQ:HOLX) New Year’s resolution is to spend more time looking within, according to newly appointed CEO Stephen MacMillan.
sBioMed
Voices of 2012: A look at some of our best interviews of the year
|
"We play a critical role in managing and moving market share. I think the device sector has not necessarily acknowledged the role of the GPOs, but I think increasingly, as products mature in particular, GPOs play a vital role in helping to drive market share up on behalf of a supplier." — Novation CEO Jody Hatcher Boston Scientific’s Irish ops pulled down $1.4B last year | Wall Street Beat Boston Scientific (NYSE:BSX) posted pre-tax profits of $1.4 billion from its Irish unit and other foreign subsidiaries last year, according to the Irish Times. Marlborough, Mass.-based medical device company Boston Scientific is 1 of the Emerald Isle’s largest employers, with a 4,500-employee workforce there. sBioMed taps ex-Stryker CEO MacMillan as CEOFooter
|
